Department of Basic and Clinical Sciences, Albany College of Pharmacy and Health Sciences, 106 New Scotland Ave, Albany, NY, 12208, USA.
Rutgers Cancer Institute of New Jersey, Rutgers the State University of New Jersey, New Brunswick, NJ, 08903, USA.
Virol J. 2018 Mar 27;15(1):53. doi: 10.1186/s12985-018-0959-x.
The tumor suppressor gene p53 has been found to suppress HIV infection by various mechanisms, but the inhibition of HIV at an early stage of replication by host cell p53 and its downstream gene p21 has not been well studied.
VSV-G pseudotyped HIV-1 or HIV-2 viruses with GFP or luciferase reporter gene were used to infect HCT116 p53 cells, HCT116 p53 cells and hMDMs. The infections were detected by flow cytometry or measured by luciferase assay. Reverse transcription products were quantified by a TaqMan real time PCR. siRNA knockdown experiments were applied to study potential roles of p53 and p21 genes in their restriction to HIV infection. Western blot experiments were used to analyze changes in gene expression.
The infection of HIV-1 was inhibited in HCT116 p53 cells in comparison to HCT116 p53 cells. The fold of inhibition was largely increased when cell cycle switched from cycling to non-cycling status. Further analysis showed that both p53 and p21 expressions were upregulated in non-cycling HCT116 p53 cells and HIV-1 reverse transcription was subsequently inhibited. siRNA knockdown of either p53 or p21 rescued HIV-1 reverse transcription from the inhibition in non-cycling HCT116 p53 cells. It was identified that the observed restrictions by p53 and p21 were associated with the suppression of RNR2 expression and phosphorylation of SAMHD1. These observations were confirmed by using siRNA knockdown experiments. In addition, p53 also inhibited HIV-2 infection in HCT116 p53 cells and siRNA knockdown of p21 increased HIV-2 infection in hMDMs. Finally the expressions of p53 and p21 were found to be induced in hMDMs shortly after HIV-1 infection.
The p53 and its downstream gene p21 interfere with HIV early stage of replication in non-cycling cells and hMDMs.
肿瘤抑制基因 p53 通过多种机制被发现可以抑制 HIV 感染,但宿主细胞 p53 及其下游基因 p21 对 HIV 复制早期的抑制作用尚未得到很好的研究。
使用带有 GFP 或 luciferase 报告基因的 VSV-G 假型 HIV-1 或 HIV-2 病毒感染 HCT116 p53 细胞、HCT116 p53 细胞和 hMDMs。通过流式细胞术或 luciferase 测定检测感染情况。通过 TaqMan 实时 PCR 定量逆转录产物。siRNA 敲低实验用于研究 p53 和 p21 基因在其对 HIV 感染的限制中的潜在作用。Western blot 实验用于分析基因表达的变化。
与 HCT116 p53 细胞相比,HIV-1 的感染在 HCT116 p53 细胞中受到抑制。当细胞周期从循环状态切换到非循环状态时,抑制的幅度大大增加。进一步分析表明,非循环 HCT116 p53 细胞中 p53 和 p21 的表达均上调,随后 HIV-1 逆转录受到抑制。siRNA 敲低 p53 或 p21 均可从非循环 HCT116 p53 细胞的抑制中拯救 HIV-1 逆转录。确定 p53 和 p21 观察到的限制与 RNR2 表达的抑制和 SAMHD1 的磷酸化有关。这些观察结果通过 siRNA 敲低实验得到证实。此外,p53 还抑制 HCT116 p53 细胞中的 HIV-2 感染,siRNA 敲低 p21 增加 hMDMs 中的 HIV-2 感染。最后,在 hMDMs 感染 HIV-1 后不久,发现 p53 和 p21 的表达被诱导。
p53 和其下游基因 p21 干扰非循环细胞和 hMDMs 中 HIV 的早期复制阶段。